Ion Beam Applications SA
Luk Herremans has a diverse work experience spanning various industries. Luk joined IBA in 2014 and has held several key positions, including Chief Market Officer and Executive Vice President. Prior to that, they co-founded and owned Medwings SA and was the Owner and Managing Director of BrachySolutions. Luk also served as the Vice President for Sales, Marketing & Business Development at IBt and IBt Bebig. Their early career includes roles at CR Bard and K.U.Leuven. Throughout their career, Luk has demonstrated expertise in sales, marketing, and business development.
Luk Herremans briefly studied Business Administration at KU Leuven in 2004-2005. Prior to that, in 1997-2000, they pursued a Masters in Physiotherapy at the same university. There is no information available regarding their education at Katholieke Universiteit Brussel.
This person is not in any teams
This person is not in any offices
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.